— Know what they know.
Not Investment Advice
Also trades as: WGSWW (NASDAQ) · $vol 0M

WGS NASDAQ

GeneDx Holdings Corp.
1W: +21.8% 1M: -32.2% 3M: -42.3% YTD: -64.2% 1Y: -34.4% 3Y: +650.1% 5Y: -87.1%
$47.31
-0.02 (-0.04%)
 
Weekly Expected Move ±27.4%
$18 $30 $41 $52 $63
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Sell · Power 38 · $1.4B mcap · 26M float · 4.48% daily turnover · Short 56% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
52.9 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -9.4%  ·  5Y Avg: -127.8%
Cost Advantage
40
Intangibles
69
Switching Cost
57
Network Effect
47
Scale
42
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. WGS shows a Weak competitive edge (52.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -9.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$70
Low
$79
Avg Target
$90
High
Based on 5 analysts since May 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$105.00
Analysts9
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-05 Craig-Hallum Bill Bonello $70 $85 +15 +138.8% $35.59
2026-05-05 BTIG $170 $90 -80 +32.5% $67.93
2026-05-05 Guggenheim $170 $70 -100 +3.0% $67.93
2026-05-05 Canaccord Genuity Kyle Mikson $100 $75 -25 +10.4% $67.93
2026-05-05 Wells Fargo Brandon Couillard $155 $75 -80 +10.4% $67.93
2026-04-20 Canaccord Genuity $170 $100 -70 +47.7% $67.72
2026-02-24 BTIG Mark Massaro $200 $170 -30 +95.2% $87.08
2026-02-24 Piper Sandler David Westenberg $120 $130 +10 +49.3% $87.08
2026-02-23 Jefferies $21 $150 +129 +72.3% $87.08
2025-12-22 Canaccord Genuity $160 $170 +10 +21.0% $140.44
2025-12-15 Wells Fargo $34 $155 +121 +2.4% $151.37
2025-12-12 BTIG $165 $200 +35 +28.7% $155.36
2025-10-29 BTIG $45 $165 +120 +20.1% $137.40
2025-10-29 Canaccord Genuity $155 $160 +5 +16.4% $137.47
2025-10-29 Guggenheim Initiated $170 +23.7% $137.47
2025-10-20 Canaccord Genuity Initiated $155 +28.2% $120.94
2025-08-04 Piper Sandler Initiated $120 +10.8% $108.35
2024-10-24 Craig-Hallum Bill Bonello $43 $70 +27 +20.7% $58.00
2024-08-27 Wells Fargo Brandon Couillard Initiated $34 -3.8% $35.35
2024-07-31 BTIG Mark Massaro $35 $45 +10 +49.4% $30.13
2024-07-10 Craig-Hallum Bill Bonello Initiated $43 +44.2% $29.81
2024-06-26 BTIG Mark Massaro $19 $35 +16 +33.6% $26.19
2024-06-03 Jefferies Tycho Peterson Initiated $21 +7.1% $19.61
2024-04-30 BTIG Mark Massaro Initiated $19 +72.7% $11.00

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. WGS receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-02-26 C- D+
2026-02-23 C C-
2026-01-03 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

24 Grade D
Profitability
20
Balance Sheet
22
Earnings Quality
38
Growth
52
Value
33
Momentum
50
Safety
30
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. WGS scores highest in Growth (52/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.62
Distress Zone
Piotroski F-Score
3/9
Beneish M-Score
-2.19
Unlikely Manipulator
Ohlson O-Score
-6.27
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BB-
Score: 39.3/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.12x
Accruals: -13.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. WGS scores 1.62, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. WGS scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. WGS's score of -2.19 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. WGS's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. WGS receives an estimated rating of BB- (score: 39.3/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-17.84x
PEG
-0.00x
P/S
3.17x
P/B
5.46x
P/FCF
-65.75x
P/OCF
EV/EBITDA
-38.44x
EV/Revenue
4.21x
EV/EBIT
-24.91x
EV/FCF
-65.08x
Earnings Yield
-4.13%
FCF Yield
-1.52%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. WGS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.004
NI / EBT
×
Interest Burden
1.035
EBT / EBIT
×
EBIT Margin
-0.169
EBIT / Rev
×
Asset Turnover
0.895
Rev / Assets
×
Equity Multiplier
1.788
Assets / Equity
=
ROE
-28.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. WGS's ROE of -28.1% is driven by Asset Turnover (0.895), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1393 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$47.31
Median 1Y
$18.81
5th Pctile
$2.80
95th Pctile
$125.86
Ann. Volatility
107.4%
Analyst Target
$105.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Katherine Stueland
Chief Executive Officer
$715,869 $11,738,600 $13,547,219
Kevin Feeley Financial
ancial Officer
$500,600 $3,756,926 $4,688,926
Bryan Dechairo Operating
rating Officer
$436,154 $2,699,971 $3,582,375

CEO Pay Ratio

74:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $13,547,219
Avg Employee Cost (SGA/emp): $184,018
Employees: 1,300

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,300
+30.0% YoY
Revenue / Employee
$328,876
Rev: $427,539,000
Profit / Employee
$-16,170
NI: $-21,021,000
SGA / Employee
$184,018
Avg labor cost proxy
R&D / Employee
$55,405
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -82.9% -75.4% -1.3% -66.6% -86.8% -1.4% -1.7% -1.7% -1.5% -1.4% -73.0% -56.1% -48.8% -34.7% -22.1% -16.3% 0.6% 0.9% -7.6% -28.1% -28.12%
ROA -1.4% -1.3% -61.0% -32.5% -42.3% -69.7% -99.9% -97.0% -89.9% -83.5% -36.5% -28.0% -24.4% -17.3% -12.5% -9.2% 0.3% 0.5% -4.2% -15.7% -15.73%
ROIC 4.8% 5.9% -17.3% -13.1% -17.7% -17.8% -2.7% -2.6% -2.2% -2.0% -65.6% -48.6% -33.7% -20.9% -8.3% -5.1% 2.3% 3.8% -3.4% -9.4% -9.35%
ROCE -2.0% -1.8% -53.6% -28.2% -47.8% -75.2% -1.5% -1.5% -1.3% -1.1% -48.1% -36.6% -30.1% -22.7% -12.9% -9.0% 1.9% 2.2% -4.0% -16.2% -16.23%
Gross Margin -2.5% -19.2% 15.9% 10.4% -81.8% 16.3% -26.6% 35.3% 38.5% 47.4% 53.6% 59.9% 60.9% 62.2% 69.2% 67.1% 69.0% 72.4% 65.2% 66.7% 66.71%
Operating Margin -96.7% -2.0% -2.0% -1.7% -4.5% -1.1% -5.3% -1.4% -1.1% -80.6% -44.7% -21.9% -15.0% -10.1% 9.2% -5.2% 8.7% -2.8% -11.3% -25.6% -25.61%
Net Margin -98.2% 75.8% -69.9% -1.4% -2.4% -93.2% -5.0% -1.4% -95.9% -79.3% -44.9% -32.4% -41.4% -10.8% 5.7% -7.5% 10.5% -6.5% -14.6% -61.9% -61.92%
EBITDA Margin -84.7% 90.1% -58.7% -1.3% -3.5% -96.5% -4.5% -1.2% -84.8% -48.8% -34.0% -23.2% -33.0% -2.4% 15.0% 0.3% 17.1% -0.3% -9.0% -53.7% -53.68%
FCF Margin -61.0% -83.1% -98.3% -1.2% -1.6% -1.4% -1.4% -1.4% -1.2% -1.1% -91.6% -66.0% -39.4% -22.4% -11.1% -4.0% 0.2% 3.8% 3.3% -6.5% -6.47%
OCF Margin -49.0% -71.8% -89.7% -1.1% -1.5% -1.3% -1.4% -1.3% -1.1% -1.0% -88.8% -63.4% -37.7% -20.6% -9.3% -0.6% 3.6% 8.3% 7.8% -2.1% -2.10%
ROE 3Y Avg snapshot only -33.40%
ROE 5Y Avg snapshot only -68.80%
ROA 3Y Avg snapshot only -18.36%
ROIC 3Y Avg snapshot only -44.02%
ROIC Economic snapshot only -5.99%
Cash ROA snapshot only -1.63%
Cash ROIC snapshot only -3.22%
CROIC snapshot only -9.92%
NOPAT Margin snapshot only -6.10%
Pretax Margin snapshot only -17.50%
R&D / Revenue snapshot only 17.74%
SGA / Revenue snapshot only 59.49%
SBC / Revenue snapshot only 8.40%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -7.15 -4.82 -4.38 -5.74 -2.50 -1.19 -0.19 -0.45 -0.31 -0.20 -0.41 -1.76 -5.92 -13.77 -39.68 -64.63 1953.47 1489.52 -166.38 -24.21 -17.837
P/S Ratio 14.85 7.31 5.08 3.72 2.23 1.45 0.44 1.08 0.64 0.45 0.35 1.07 2.86 4.30 6.79 7.55 7.58 7.71 8.18 4.26 3.173
P/B Ratio 592.84 363.81 2.78 1.93 1.10 0.86 0.40 0.95 0.60 0.37 0.31 1.04 3.05 5.04 8.46 10.17 11.20 12.65 11.35 6.11 5.461
P/FCF -24.35 -8.80 -5.16 -3.04 -1.40 -1.03 -0.31 -0.79 -0.56 -0.43 -0.38 -1.62 -7.25 -19.17 -61.04 -190.63 3309.14 200.61 245.23 -65.75 -65.751
P/OCF 210.89 93.49 105.10
EV/EBITDA -7.30 -4.96 -3.21 -3.64 -0.30 0.11 -0.08 -0.34 -0.20 -0.09 -0.44 -2.25 -8.23 -19.27 -81.29 -235.01 89.76 96.72 524.92 -38.44 -38.442
EV/Revenue 14.48 7.01 3.34 1.89 0.30 -0.14 0.18 0.81 0.39 0.16 0.30 1.03 2.81 4.26 6.71 7.48 7.51 7.65 8.14 4.21 4.212
EV/EBIT -7.02 -4.67 -2.92 -2.99 -0.27 0.10 -0.07 -0.31 -0.18 -0.07 -0.35 -1.73 -6.32 -13.96 -43.46 -75.05 390.81 388.69 -187.02 -24.91 -24.908
EV/FCF -23.75 -8.44 -3.40 -1.55 -0.19 0.10 -0.13 -0.60 -0.33 -0.15 -0.33 -1.55 -7.14 -19.00 -60.31 -188.72 3279.00 198.99 243.87 -65.08 -65.076
Earnings Yield -14.0% -20.7% -22.8% -17.4% -40.0% -84.0% -5.4% -2.2% -3.3% -4.9% -2.5% -56.7% -16.9% -7.3% -2.5% -1.5% 0.1% 0.1% -0.6% -4.1% -4.13%
FCF Yield -4.1% -11.4% -19.4% -32.9% -71.7% -96.6% -3.3% -1.3% -1.8% -2.4% -2.6% -61.5% -13.8% -5.2% -1.6% -0.5% 0.0% 0.5% 0.4% -1.5% -1.52%
Price/Tangible Book snapshot only 14.930
EV/Gross Profit snapshot only 6.163
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.37 2.37 4.77 4.77 4.77 4.77 1.47 1.47 1.47 1.47 3.10 3.10 3.10 3.10 3.61 3.61 3.61 3.61 2.46 2.46 2.463
Quick Ratio 2.03 2.03 4.44 4.44 4.44 4.44 1.38 1.38 1.38 1.38 2.95 2.95 2.95 2.95 3.42 3.42 3.42 3.42 2.34 2.34 2.335
Debt/Equity 9.86 9.86 0.08 0.08 0.08 0.08 0.30 0.30 0.30 0.30 0.53 0.53 0.53 0.53 0.47 0.47 0.47 0.47 0.49 0.49 0.493
Net Debt/Equity -14.79 -14.79 -0.95 -0.95 -0.95 -0.95 -0.24 -0.24 -0.24 -0.24 -0.05 -0.05 -0.05 -0.05 -0.10 -0.10 -0.10 -0.10 -0.06 -0.06 -0.063
Debt/Assets 0.17 0.17 0.06 0.06 0.06 0.06 0.14 0.14 0.14 0.14 0.29 0.29 0.29 0.29 0.28 0.28 0.28 0.28 0.27 0.27 0.266
Debt/EBITDA -0.12 -0.14 -0.15 -0.31 -0.17 -0.11 -0.14 -0.15 -0.17 -0.20 -0.86 -1.18 -1.44 -2.03 -4.61 -11.06 3.83 3.65 22.93 -3.13 -3.133
Net Debt/EBITDA 0.19 0.21 1.66 3.50 1.93 1.19 0.11 0.11 0.13 0.15 0.07 0.10 0.12 0.18 0.99 2.38 -0.83 -0.79 -2.92 0.40 0.399
Interest Coverage -172.73 -118.20 -85.64 -43.78 -72.43 -109.50 -189.84 -187.56 -170.36 -207.32 -72.99 -59.82 -43.95 -24.64 -15.56 -10.69 2.32 2.91 -7.32 -28.62 -28.615
Equity Multiplier 57.35 57.35 1.43 1.43 1.43 1.43 2.15 2.15 2.15 2.15 1.84 1.84 1.84 1.84 1.71 1.71 1.71 1.71 1.85 1.85 1.850
Cash Ratio snapshot only 1.573
Debt Service Coverage snapshot only -18.541
Cash to Debt snapshot only 1.127
FCF to Debt snapshot only -0.189
Defensive Interval snapshot only 266.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.70 0.87 0.53 0.50 0.47 0.57 0.43 0.41 0.43 0.38 0.42 0.46 0.51 0.55 0.73 0.79 0.86 0.96 0.86 0.89 0.895
Inventory Turnover 7.22 9.28 7.42 6.73 7.33 7.96 11.10 10.23 8.71 6.94 10.03 9.77 9.56 9.65 11.43 11.81 12.24 12.57 10.95 11.39 11.391
Receivables Turnover 5.47 6.81 7.25 6.90 6.53 7.90 6.79 6.48 6.84 5.97 5.40 5.92 6.50 7.13 8.75 9.46 10.38 11.52 7.65 7.92 7.919
Payables Turnover 6.74 8.67 6.07 5.50 6.00 6.51 5.76 5.31 4.52 3.61 4.00 3.90 3.81 3.85 12.21 12.61 13.07 13.42 25.87 26.91 26.906
DSO 67 54 50 53 56 46 54 56 53 61 68 62 56 51 42 39 35 32 48 46 46.1 days
DIO 51 39 49 54 50 46 33 36 42 53 36 37 38 38 32 31 30 29 33 32 32.0 days
DPO 54 42 60 66 61 56 63 69 81 101 91 94 96 95 30 29 28 27 14 14 13.6 days
Cash Conversion Cycle 63 51 39 41 45 36 23 23 15 12 13 5 -1 -6 44 41 37 34 67 65 64.6 days
Fixed Asset Turnover snapshot only 6.406
Operating Cycle snapshot only 78.1 days
Cash Velocity snapshot only 2.584
Capital Intensity snapshot only 1.288
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 2.3% 57.6% 9.1% 5.9% 10.6% 10.9% 23.7% -10.7% -13.7% -0.9% 3.1% 29.4% 50.8% 48.8% 48.7% 50.5% 40.0% 34.1% 34.09%
Net Income -95.4% 58.8% 53.2% 15.2% -1.2% -3.1% -1.9% -63.5% 68.0% 74.7% 76.2% 81.8% 70.3% 71.4% 1.0% 1.0% 59.8% -1.0% -1.02%
EPS -50.3% 68.7% 74.2% 53.1% -38.9% -50.5% -16.8% 26.9% 85.5% 80.5% 77.3% 82.7% 71.4% 73.5% 1.0% 1.0% 59.6% -93.5% -93.54%
FCF -6.0% -2.2% -1.9% -78.1% -59.9% -23.2% 10.7% 31.6% 44.3% 51.8% 64.7% 72.8% 81.7% 91.1% 1.0% 1.3% 1.4% -1.2% -1.19%
EBITDA -82.0% 65.8% 45.2% -0.3% -1.5% -4.1% -1.4% -27.1% 74.6% 80.9% 81.4% 85.0% 81.9% 89.6% 1.4% 1.5% 1.3% -3.6% -3.62%
Op. Income -2.6% -5.4% -24.3% -0.7% -49.6% -88.4% -15.7% -4.6% 73.0% 79.0% 82.4% 88.0% 87.1% 89.5% 1.1% 1.2% 45.9% -1.4% -1.42%
OCF Growth snapshot only -3.90%
Asset Growth snapshot only 35.96%
Equity Growth snapshot only 25.66%
Debt Growth snapshot only 30.80%
Shares Change snapshot only 4.22%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 46.9% 20.1% 11.6% 7.0% 12.9% 17.8% 23.8% 20.3% 22.1% 25.5% 25.51%
Revenue 5Y 46.2% 28.1% 28.14%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 5.0% 2.4%
Gross Profit 5Y 2.7%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 18.5% 18.5% 18.5% 18.5% -8.9% -8.9% -8.9% -8.9% 1.5% 1.5% 1.50%
Assets 5Y 17.8% 17.8% 17.77%
Equity 3Y 2.7% 2.7% 2.7% 2.7% -14.2% -14.2% -14.2% -14.2% 6.7% 6.7% 6.70%
Book Value 3Y 1.2% 1.2% 1.2% 1.3% -44.5% -45.0% -39.9% -36.7% -19.0% -6.0% -5.99%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.85 0.91 0.93 0.23 0.53 0.76 0.93 0.36 0.47 0.73 0.85 0.72 0.91 0.89 0.895
Earnings Stability 0.94 0.29 0.16 0.48 0.10 0.01 0.09 0.22 0.03 0.20 0.39 0.53 0.17 0.29 0.287
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.20 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 12.47 34.24 39.71 36.26 0.63 0.63 0.68 0.90 1.25 1.19 1.24 1.10 0.42 0.12 0.122
Gross Margin Trend -0.11 -0.07 0.21 0.24 0.51 0.53 0.55 0.49 0.47 0.44 0.33 0.30 0.14 0.10 0.104
FCF Margin Trend -0.70 -0.45 -0.05 0.04 0.29 0.63 0.98 1.01 1.06 0.97 0.78 0.69 0.55 0.29 0.285
Sustainable Growth Rate 0.6% 0.9%
Internal Growth Rate 0.3% 0.5%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.24 0.47 0.78 1.76 1.70 1.09 0.58 0.55 0.53 0.47 1.02 1.04 0.78 0.66 0.55 0.05 9.26 15.93 -1.58 0.12 0.120
FCF/OCF 1.24 1.16 1.10 1.07 1.05 1.05 1.04 1.04 1.04 1.03 1.03 1.04 1.05 1.09 1.19 6.88 0.06 0.47 0.43 3.08 3.077
FCF/Net Income snapshot only 0.368
CapEx/Revenue 12.0% 11.3% 8.6% 8.5% 8.3% 7.2% 6.1% 4.9% 4.4% 3.0% 2.8% 2.6% 1.8% 1.8% 1.8% 3.4% 3.4% 4.4% 4.4% 4.4% 4.37%
CapEx/Depreciation snapshot only 0.734
Accruals Ratio -1.10 -0.69 -0.14 0.25 0.29 0.06 -0.42 -0.44 -0.42 -0.44 0.01 0.01 -0.05 -0.06 -0.06 -0.09 -0.03 -0.07 -0.11 -0.14 -0.138
Sloan Accruals snapshot only -0.020
Cash Flow Adequacy snapshot only -0.481
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% -49.7% -73.6% -1.1% -2.3% -59.1% 0.0% -56.0% -36.1% -58.2% -2.0% -3.2% -0.0% -1.3% -2.2% -2.5% -2.3% -1.9% 0.0% -4.4% -4.40%
Total Shareholder Return 0.0% -49.7% -73.6% -1.1% -2.3% -59.1% 0.0% -56.0% -36.1% -58.2% -2.0% -3.2% -0.0% -1.3% -2.2% -2.5% -2.3% -1.9% 0.0% -4.4% -4.40%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 0.78 0.85 0.92 0.92 1.00 1.00 0.99 0.99 0.99 0.99 0.99 1.00 0.92 0.83 0.99 1.00 1.004
Interest Burden (EBT/EBIT) 1.01 1.01 1.01 1.02 1.01 0.97 0.98 0.98 0.97 1.01 1.02 1.03 1.09 1.03 1.12 1.17 0.22 0.32 1.14 1.03 1.035
EBIT Margin -2.06 -1.50 -1.14 -0.63 -1.13 -1.47 -2.59 -2.65 -2.16 -2.20 -0.85 -0.59 -0.45 -0.31 -0.15 -0.10 0.02 0.02 -0.04 -0.17 -0.169
Asset Turnover 0.70 0.87 0.53 0.50 0.47 0.57 0.43 0.41 0.43 0.38 0.42 0.46 0.51 0.55 0.73 0.79 0.86 0.96 0.86 0.89 0.895
Equity Multiplier 57.35 57.35 2.05 2.05 2.05 2.05 1.71 1.71 1.71 1.71 2.00 2.00 2.00 2.00 1.77 1.77 1.77 1.77 1.79 1.79 1.788
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-64.62 $-51.91 $-33.57 $-17.66 $-16.64 $-24.32 $-46.63 $-26.57 $-19.44 $-17.79 $-6.77 $-5.18 $-4.41 $-3.08 $-1.94 $-1.37 $0.05 $0.07 $-0.78 $-2.65 $-2.65
Book Value/Share $0.78 $0.69 $53.03 $52.41 $37.92 $33.64 $21.55 $12.65 $9.98 $9.84 $8.78 $8.75 $8.57 $8.42 $9.09 $8.71 $8.24 $8.52 $11.46 $10.51 $8.66
Tangible Book/Share $0.78 $0.69 $53.03 $52.41 $37.92 $33.64 $5.70 $3.34 $2.64 $2.60 $2.13 $2.13 $2.08 $2.04 $3.21 $3.08 $2.91 $3.01 $4.69 $4.30 $4.30
Revenue/Share $31.13 $34.26 $29.00 $27.27 $18.67 $20.03 $19.93 $11.16 $9.30 $8.01 $7.80 $8.51 $9.15 $9.86 $11.32 $11.73 $12.18 $13.97 $15.90 $15.09 $15.09
FCF/Share $-18.98 $-28.46 $-28.50 $-33.33 $-29.79 $-28.00 $-28.33 $-15.16 $-10.72 $-8.56 $-7.14 $-5.62 $-3.61 $-2.21 $-1.26 $-0.46 $0.03 $0.54 $0.53 $-0.98 $-0.98
OCF/Share $-15.26 $-24.60 $-26.02 $-31.02 $-28.24 $-26.56 $-27.11 $-14.62 $-10.31 $-8.33 $-6.92 $-5.40 $-3.45 $-2.04 $-1.06 $-0.07 $0.44 $1.15 $1.24 $-0.32 $-0.32
Cash/Share $19.22 $16.97 $54.74 $54.09 $39.14 $34.72 $11.67 $6.85 $5.41 $5.33 $5.01 $4.99 $4.89 $4.80 $5.23 $5.02 $4.75 $4.90 $6.37 $5.84 $5.82
EBITDA/Share $-61.74 $-48.40 $-30.20 $-14.20 $-18.60 $-26.83 $-46.67 $-26.50 $-17.62 $-15.26 $-5.36 $-3.89 $-3.13 $-2.18 $-0.93 $-0.37 $1.02 $1.10 $0.25 $-1.65 $-1.65
Debt/Share $7.69 $6.79 $4.49 $4.44 $3.21 $2.85 $6.55 $3.84 $3.03 $2.99 $4.61 $4.60 $4.50 $4.42 $4.30 $4.13 $3.90 $4.03 $5.65 $5.18 $5.18
Net Debt/Share $-11.53 $-10.18 $-50.25 $-49.66 $-35.93 $-31.87 $-5.12 $-3.00 $-2.37 $-2.34 $-0.40 $-0.40 $-0.39 $-0.38 $-0.93 $-0.89 $-0.84 $-0.87 $-0.72 $-0.66 $-0.66
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 1.620
Altman Z-Prime snapshot only 0.648
Piotroski F-Score 2 2 5 4 3 4 2 3 3 2 3 4 5 5 6 6 8 8 6 3 3
Beneish M-Score -3.79 -2.74 -2.83 -3.20 7.92 8.48 7.10 8.84 -3.52 -2.71 -3.05 -3.04 -2.53 -2.77 -2.45 -2.70 -2.09 -2.19 -2.192
Ohlson O-Score snapshot only -6.275
ROIC (Greenblatt) snapshot only -32.76%
Net-Net WC snapshot only $0.21
EVA snapshot only $-55897860.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB-
Credit Score 25.15 21.21 46.32 42.17 33.46 33.71 26.72 27.40 27.40 27.37 32.24 32.34 31.84 31.93 57.11 62.61 71.44 74.95 56.31 39.35 39.347
Credit Grade snapshot only 13
Credit Trend snapshot only -23.261
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 31
Sector Credit Rank snapshot only 31

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms